EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer Autor Fei Ye BS, Xiao Yuan SM, Wanjun Yu MM, Yali Ma MM, Chaoming Mao MD, Xiaoqin Li MD, Jian Li MD, Chunhua Dai MD, Fenhong Qian MD, Junrong Li MD, Xiujuan Fan BS, Yuepeng Zhou MM, Dongfang Dai MD, Deqiang Wang MD, Deyu Chen MD, Sheng Xia MD, Minghui Zhang MD

Získat plný text